Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1158 Articles

Paul Ausick | Jun 23, 2018 at 8:45 AM EDT

General Electric Exits the Dow as Year’s Worst Performing Stock

General Electric is being dropped from its spot on the Dow Jones industrial average index and it leaves with the…

Paul Ausick | Jun 16, 2018 at 8:17 AM EDT

General Electric Firms Up Grip as Dow’s Worst-Performing Stock

For the second week in a row, General Electric ranked as the worst performing stock among the 30 equities that…

Lee Jackson | Jun 15, 2018 at 10:07 AM EDT

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a…

Paul Ausick | Jun 9, 2018 at 8:24 AM EDT

General Electric Drops Into Ranking as Dow’s Worst-Performing Stock

General Electric ended Procter & Gamble's run as the worst performing Dow stock last week. GE shares dropped more than…

Paul Ausick | Jun 2, 2018 at 8:35 AM EDT

Procter & Gamble Still the Dow’s Worst-Performing Stock

The worst-performing Dow 30 stock for the year to date remains consumer products giant Procter & Gamble.

Lee Jackson | Jun 1, 2018 at 10:30 AM EDT

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

It’s no surprise that it was only a matter of time before the usage and storage of big data and…

Paul Ausick | May 26, 2018 at 8:55 AM EDT

Procter & Gamble Remains the Dow’s Worst Performing Stock

Procter & Gamble shares added more than 1% last week but that was not enough to allow the consumer products…

Paul Ausick | May 24, 2018 at 4:01 PM EDT

Exxon Mobil, Chevron Clobber the Dow Thursday

Exxon Mobil, Chevron, Johnson & Johnson, and JPMorgan led the Dow to a lower close Thursday.

Paul Ausick | May 19, 2018 at 9:15 AM EDT

Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock

The Dow's worst performing stock for the past 5 weeks has been consumer products giant Procter & Gamble. Last week…

Chris Lange | May 19, 2018 at 8:25 AM EDT

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.

Paul Ausick | May 18, 2018 at 9:45 AM EDT

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received…

Paul Ausick | May 17, 2018 at 4:01 PM EDT

Walmart, Cisco Weigh on the Dow Thursday

Cisco, Walmart, Merck, and Johnson & Johnson were among the leading losers on the Dow Thursday.

Paul Ausick | May 12, 2018 at 9:10 AM EDT

Procter & Gamble Clings to Ranking as Dow’s Worst Performing Stock

Procter & Gamble was able to add a bit to its share price last week, but not enough for it…

Paul Ausick | May 11, 2018 at 4:01 PM EDT

Merck, Verizon Pace the Dow Friday

The Dow is set to close with a modest gain Friday led by Verizon, Merck, UnitedHealth, and Johnson & Johnson.

Paul Ausick | May 5, 2018 at 8:50 AM EDT

Dow’s Worst Performing Stock Still Procter & Gamble

Procter & Gamble is holding on to its ranking as the worst-performing stock among the 30 equities that comprise the…

1 … 28 29 30 31 32 … 78

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

General Electric Exits the Dow as Year’s Worst Performing Stock

General Electric Firms Up Grip as Dow’s Worst-Performing Stock

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

General Electric Drops Into Ranking as Dow’s Worst-Performing Stock

Procter & Gamble Still the Dow’s Worst-Performing Stock

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Procter & Gamble Remains the Dow’s Worst Performing Stock

Exxon Mobil, Chevron Clobber the Dow Thursday

Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

Walmart, Cisco Weigh on the Dow Thursday

Procter & Gamble Clings to Ranking as Dow’s Worst Performing Stock

Merck, Verizon Pace the Dow Friday

Dow’s Worst Performing Stock Still Procter & Gamble

$10,000 Invested in XLK on New Year’s Eve Is Worth $13,434 Today

Is Ripple (XRP) Still A Good Crypto to Buy In 2026?

$10,000 Invested in XLK on New Year’s Eve Is Worth $13,434 Today

58% of Americans Think a 401(k) Balance Is Enough. 48% Have No Plan to Use It.

How a 73-Year-Old's First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent

$10,000 Invested in XLK on New Year’s Eve Is Worth $13,434 Today

Is Ripple (XRP) Still A Good Crypto to Buy In 2026?

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

General Electric Exits the Dow as Year’s Worst Performing Stock

General Electric Firms Up Grip as Dow’s Worst-Performing Stock

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

General Electric Drops Into Ranking as Dow’s Worst-Performing Stock

Procter & Gamble Still the Dow’s Worst-Performing Stock

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Procter & Gamble Remains the Dow’s Worst Performing Stock

Exxon Mobil, Chevron Clobber the Dow Thursday

Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

Walmart, Cisco Weigh on the Dow Thursday

Procter & Gamble Clings to Ranking as Dow’s Worst Performing Stock

Merck, Verizon Pace the Dow Friday

Dow’s Worst Performing Stock Still Procter & Gamble

$10,000 Invested in XLK on New Year’s Eve Is Worth $13,434 Today

Is Ripple (XRP) Still A Good Crypto to Buy In 2026?

$10,000 Invested in XLK on New Year’s Eve Is Worth $13,434 Today

Featured Reads

58% of Americans Think a 401(k) Balance Is Enough. 48% Have No Plan to Use It.

How a 73-Year-Old's First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent